Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00622_DB00906_nanopub.RARFW10J38wfqd2izYCoXPpKldUOd54rqb-8qWs4gZz48#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00622_DB00906 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00622_DB00906 label "DDI between Nicardipine and Tiagabine - The strong CYP3A4 inhibitor, Nicardipine, may decrease the metabolism and clearance of Tiagabine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Tiagabine if Nicardipine is initiated, discontinued or dose changed. [drugbank_resource:DB00622_DB00906]" assertion.
- drugbank_resource:DB00622_DB00906 identifier "drugbank_resource:DB00622_DB00906" assertion.
- drugbank_resource:DB00622_DB00906 title "DDI between Nicardipine and Tiagabine - The strong CYP3A4 inhibitor, Nicardipine, may decrease the metabolism and clearance of Tiagabine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Tiagabine if Nicardipine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00622 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00622_DB00906 assertion.
- drugbank:DB00906 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00622_DB00906 assertion.